Illumina pushed back against Carl Icahn’s proxy fight over the Grail deal, saying it’s committed to maximizing shareholder value as it works with regulators.

Was this article helpful?
YesNo

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close Search Window